Drug Research
Revenue Clawback Rate Increase Warned By ABPI In The UK
The Association of the British Pharmaceutical Industry (ABPI) has urged the government to take prompt action in response to the planned UK statutory revenue clawback rate increase for branded medications.
The Department of Health and Social Care (DHSC) is now...
Drug Research
Regenerative Treatment For An Impaired Kidney Restoration
An event that hasn’t happened before was demonstrated by researchers from Duke-NUS Medical School, colleagues in Germany, and the National Heart Centre Singapore (NHCS), suggesting that regenerative treatment to restore damaged kidney function could be a sure possibility. In...
Drug Research
Fatty Liver Disease Gets A Novel Drug Healing Contender
Karolinska Institute researchers have come up with a promising antibody medication candidate for the medication of non-alcoholic fatty liver disease.
There is presently no treatment for non-alcoholic fatty liver disease, which affects individuals with type 2 diabetes and can develop...
Drug Research
Singapore Witnesses A $50mn Funding In Research & Innovation
NUS Academic Medical Centre and SingHealth in Singapore have announced a gift of $50 million, which will be transformational, from the Lee Foundation that will aid in providing support for the advancement of research and innovation via programmes as...
Drug Research
Novel Research Says Actin A Key Source of Spreading Cancer
The University of Freiburg researchers have found out that the release of prometastatic factors is influenced by the skeleton of the cell, known as actin.
As per a research team that was led by Dr. Robert Grosse and Dr. Carsten...
Drug Research
Genomic Ties Announced By UK With Thailand On Health Issues
A new partnership with Thailand to share the expertise of genome sequencing, research collaboration, education and training opportunities, as well as genomics data handling will help UK patients.
A MoU has been inked between deputy Prime Minister of Thailand, Anutin...
Drug Research
South Korean Pharma Sector Attracts Despite Drug Nod Delays
According to a survey from Fitch Solutions, South Korea's pharmaceutical market attractiveness is expected to stay strong despite ongoing concerns about the country's slow pace of drug authorizations.
According to the analysis, the pharmaceutical business will remain competitive due to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read